Completed PHASE2 INTERVENTIONAL 2-arm NCT00088634

A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia

A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia

Sponsor: Sumitomo Pharma America, Inc.

Updated 10 times since 2017 Last updated: Mar 10, 2016 Started: May 31, 2004 Primary completion: Dec 31, 2004 Completion: Dec 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00088634, this PHASE2 trial focuses on Schizophrenia and remains completed. Sponsored by Sumitomo Pharma America, Inc., it has been updated 10 times since 2004, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2023 — Sep 2023 [monthly]

Completed PHASE2

▶ Show 5 earlier versions

Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

May 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sumitomo Pharma America, Inc.

Data source: Sumitomo Pharma America, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Austin, United States , Bellaire, United States , Birmingham, United States , Cerritos, United States , Clementon, United States , DeSoto, United States , Falls Church, United States , Garden Grove, United States , Hoffman Estates, United States and 9 more locations